Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Voices From the Black Community: Hepatitis C Research Participation
- Status
- COMPLETED
- Phase
- N/A
Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab + Defactinib In Pleural Mesothelioma
- Status
- WITHDRAWN
- Phase
- PHASE1
Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)
- Status
- COMPLETED
- Phase
- PHASE3
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Audit-and-feedback to Improve Antimicrobial-prescribing Among Urologists
- Status
- COMPLETED
- Phase
- NA
In Vitro Activity of Ceftolozane/Tazobactam and Imipenem/Relebactam in Clinical Isolates of Pseudomonas Aeruginosa and Enterobacterales Collected From Hematology and Oncology Patients
- Status
- UNKNOWN
- Phase
- N/A
A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
V114 and Acute Otitis Media (V114-032/PNEU-ERA)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN.
- Status
- UNKNOWN
- Phase
- N/A
A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ertugliflozin: Cardioprotective Effects on Epicardial Fat
- Status
- COMPLETED
- Phase
- EARLY_PHASE1